{"id":4903,"date":"2025-12-04T10:15:31","date_gmt":"2025-12-04T10:15:31","guid":{"rendered":"https:\/\/neurologyconf.com\/?p=4903"},"modified":"2025-12-04T10:21:41","modified_gmt":"2025-12-04T10:21:41","slug":"reinventing-migraine-care-in-europe-insights-innovation-investment-trends","status":"publish","type":"post","link":"https:\/\/clsconf.com\/neurology\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\/","title":{"rendered":"Reinventing Migraine Care in Europe: Insights, Innovation & Investment Trends"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Migraine & Headache Disorders: Market snapshot<\/a> (Europe) \ud83e\udde0\ud83d\udcca<\/strong><\/h3>

Migraine remains one of Europe\u2019s highest-burden neurological conditions \u2014 affecting tens of millions and imposing substantial human and economic costs. Recent estimates put the number of adults living with migraine in Europe at ~30\u201341 million<\/strong> (prevalence \u2248 11\u201315%<\/strong> depending on the country and study).<\/p>

Why this is a market opportunity<\/strong>
\u2022 Large patient base in working-age adults
\u2022 Rapid therapeutic innovation (CGRP monoclonal antibodies, gepants) + growth in digital therapeutics and neuromodulation
\u2022 Significant unmet needs around diagnosis, personalised prevention and treatment adherence.<\/p>

\"\"<\/strong><\/p>

10 companies active in migraine & headache in Europe (including startups & digital\/device firms)<\/strong><\/p>

  1. Novartis \/ Amgen<\/strong> \u2014 Aimovig (erenumab) \u2014 large player in anti-CGRP prevention.<\/p><\/li>

  2. Eli Lilly \/ Organon<\/strong> \u2014 Emgality (galcanezumab) and commercial partnerships for Europe.<\/p><\/li>

  3. Teva<\/strong> \u2014 AJOVY (fremanezumab) and ongoing migraine R&D \/ real-world studies.<\/p><\/li>

  4. Pfizer \/ Biohaven (Vydura \/ rimegepant)<\/strong> \u2014 oral gepant approved for acute & prophylactic use in EU.<\/p><\/li>

  5. AbbVie (BOTOX\u00ae \/ Qulipta)<\/strong> \u2014 established chronic migraine prophylaxis and new oral agents in portfolio.<\/p><\/li>

  6. CEFALY Technology (Belgium)<\/strong> \u2014 external trigeminal nerve stimulation (e-TNS) device and companion app.<\/p><\/li>

  7. Theranica (Nerivio)<\/strong> \u2014 smartphone-controlled wearable REN device (CE-marked \/ EU launches).<\/p><\/li>

  8. Neurolief (Relivion)<\/strong> \u2014 multi-channel neuromodulation headset with CE-mark for migraine.<\/p><\/li>

  9. Healint \/ Migraine Buddy (now part of Aptar Digital Health)<\/strong> \u2014 AI-enabled migraine tracking & reporting app used by clinicians and patients.<\/p><\/li>

  10. Nerivio \/ Dr. Reddy\u2019s (commercial partners)<\/strong> \u2014 device distribution and market expansion across EU countries.<\/p><\/li><\/ol>

    \u00a0<\/p>

    Workforce & care access \u2014 a reality check<\/strong>
    Neurology workforce varies across Europe, but historic surveys show an average ~6.6 neurologists per 100,000 population<\/strong> (wide country variation). That gap \u2014 plus under-diagnosis of migraine \u2014 means many sufferers rely on primary care or remain untreated.<\/p>

    How tech & AI are changing care<\/strong>
    \u2022 AI & ML<\/strong>: improving diagnostic algorithms, headache subtype classification and prediction of response to targeted therapies.\u00a0
    \u2022 Digital therapeutics & apps<\/strong>: symptom tracking, trigger detection, automated reports for clinicians and medication\/adherence support (e.g., Migraine Buddy).\u00a0
    \u2022 Wearables \/ neuromodulation<\/strong>: non-pharmacologic acute and preventive devices (CEFALY, Nerivio, Relivion) reduce reliance on systemic meds and expand outpatient care options.<\/p>

    The 4th European Congress of Neurology and Neuropsychiatry<\/strong>, taking place on February 23\u201324, 2026 at Hyatt Place Paris CDG Airport, France<\/strong>, stands as Europe\u2019s dedicated platform to address the rising burden of neurological and psychiatric disorders\u2014from migraine, Alzheimer\u2019s, stroke, sleep disorders and depression to cutting-edge neurotechnology, AI diagnostics, brain therapeutics and digital psychiatry. Under the theme \u201cBrain and Mental Health: Navigating the Future of Neurology and Psychiatry,\u201d<\/strong> this congress connects clinicians, researchers, innovators, startups, policymakers and patient-advocacy groups to shape solutions for Europe\u2019s unmet healthcare gaps. Through keynote sessions, evidence-based discussions, industry showcases and collaboration forums, the congress aims to strengthen Europe\u2019s neuro-health ecosystem, accelerate research translation, improve patient pathways, and foster innovation that drives real-world impact.<\/p>

    Register, download the brochure, submit your abstract, or explore the scientific program \u2014 and be part of the initiative creating the next era of neurological and mental health advancement.<\/strong> Early Bird Registration closes on December 15, 2025 \u2014 secure your place today.<\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

    \n\t\t\t\t\t
    \n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

    Migraine & Headache Disorders: Market snapshot (Europe) \ud83e\udde0\ud83d\udcca Migraine remains one of Europe\u2019s highest-burden neurological conditions \u2014 affecting tens of millions and imposing substantial human and economic costs. Recent estimates put the number of adults living with migraine in Europe at ~30\u201341 million (prevalence \u2248 11\u201315% depending on the country and study). Why this is…<\/p>\n","protected":false},"author":2,"featured_media":4862,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4903","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"aioseo_notices":[],"yoast_head":"\nReinventing Migraine Care in Europe: Insights, Innovation & Investment Trends<\/title>\n<meta name=\"description\" content=\"Migraine Conference: Discover how migraine burden is transforming Europe\u2019s neuro-health landscape \u2014 from patient demand and treatment gaps to emerging technologies and research leaders \u2014 and join Neurology Congress.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/clsconf.com\/neurology\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Reinventing Migraine Care in Europe: Insights, Innovation & Investment Trends\" \/>\n<meta property=\"og:description\" content=\"Migraine Conference: Discover how migraine burden is transforming Europe\u2019s neuro-health landscape \u2014 from patient demand and treatment gaps to emerging technologies and research leaders \u2014 and join Neurology Congress.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/clsconf.com\/neurology\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\/\" \/>\n<meta property=\"og:site_name\" content=\"Neurology Conference 2026 | Psychiatry Congress | Neuro Congress\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-04T10:15:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-04T10:21:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/clsconf.com\/neurology\/wp-content\/uploads\/2025\/12\/neurology-banner-image66c5de85306c0.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1926\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/#\\\/schema\\\/person\\\/985869a73316c56939b28199bbeb71e6\"},\"headline\":\"Reinventing Migraine Care in Europe: Insights, Innovation & Investment Trends\",\"datePublished\":\"2025-12-04T10:15:31+00:00\",\"dateModified\":\"2025-12-04T10:21:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\\\/\"},\"wordCount\":488,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/neurology-banner-image66c5de85306c0.webp\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/clsconf.com\\\/neurology\\\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\\\/\",\"url\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\\\/\",\"name\":\"Reinventing Migraine Care in Europe: Insights, Innovation & Investment Trends\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/neurology-banner-image66c5de85306c0.webp\",\"datePublished\":\"2025-12-04T10:15:31+00:00\",\"dateModified\":\"2025-12-04T10:21:41+00:00\",\"description\":\"Migraine Conference: Discover how migraine burden is transforming Europe\u2019s neuro-health landscape \u2014 from patient demand and treatment gaps to emerging technologies and research leaders \u2014 and join Neurology Congress.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/clsconf.com\\\/neurology\\\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\\\/#primaryimage\",\"url\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/neurology-banner-image66c5de85306c0.webp\",\"contentUrl\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/neurology-banner-image66c5de85306c0.webp\",\"width\":1926,\"height\":1000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Reinventing Migraine Care in Europe: Insights, Innovation & Investment Trends\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/#website\",\"url\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/\",\"name\":\"Neurology Conference 2026 | Psychiatry Congress | Neuro Congress\",\"description\":\"Join the leading Neurology Conference 2026, a global platform for neurologists, psychiatrists, and researchers. Explore the latest advancements in neurology, neuroscience, and psychiatry. Register now! Embark on a transformative journey at the 4th European Congress of Neurology and Neuropsychiatry in Paris, France, on February 23-24, 2026\",\"publisher\":{\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/#organization\"},\"alternateName\":\"Neurology Conference | Psychiatry Conference\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/#organization\",\"name\":\"CLS Event and Publication\",\"alternateName\":\"CLS Event and Publication\",\"url\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/cropped-Logo-2026-1-Picsart-BackgroundRemover-1-1.png\",\"contentUrl\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/cropped-Logo-2026-1-Picsart-BackgroundRemover-1-1.png\",\"width\":500,\"height\":282,\"caption\":\"CLS Event and Publication\"},\"image\":{\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"description\":\"CLS Event and Publication Ltd is a UK-based company specialising in international conferences, exhibitions, and scientific publishing. We bring together academics, researchers, healthcare professionals, and industry leaders to share expertise, foster collaborations, and showcase innovations.\",\"email\":\"info@clsconf.com\",\"legalName\":\"CLS EVENTS\",\"foundingDate\":\"2021-02-01\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"11\",\"maxValue\":\"50\"},\"publishingPrinciples\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/refundpolicy-faqs\\\/\",\"ownershipFundingInfo\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/about-us\\\/\",\"actionableFeedbackPolicy\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/scientific-poster-presentation-guidelines\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/#\\\/schema\\\/person\\\/985869a73316c56939b28199bbeb71e6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9338361e5fda6e1a51464119e2265a669174adbf4e41e0060b272dd89c05786a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9338361e5fda6e1a51464119e2265a669174adbf4e41e0060b272dd89c05786a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9338361e5fda6e1a51464119e2265a669174adbf4e41e0060b272dd89c05786a?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\\\/\\\/clsconf.com\\\/neurology\\\/author\\\/expertmeetcogmail-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Reinventing Migraine Care in Europe: Insights, Innovation & Investment Trends","description":"Migraine Conference: Discover how migraine burden is transforming Europe\u2019s neuro-health landscape \u2014 from patient demand and treatment gaps to emerging technologies and research leaders \u2014 and join Neurology Congress.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/clsconf.com\/neurology\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\/","og_locale":"en_US","og_type":"article","og_title":"Reinventing Migraine Care in Europe: Insights, Innovation & Investment Trends","og_description":"Migraine Conference: Discover how migraine burden is transforming Europe\u2019s neuro-health landscape \u2014 from patient demand and treatment gaps to emerging technologies and research leaders \u2014 and join Neurology Congress.","og_url":"https:\/\/clsconf.com\/neurology\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\/","og_site_name":"Neurology Conference 2026 | Psychiatry Congress | Neuro Congress","article_published_time":"2025-12-04T10:15:31+00:00","article_modified_time":"2025-12-04T10:21:41+00:00","og_image":[{"width":1926,"height":1000,"url":"https:\/\/clsconf.com\/neurology\/wp-content\/uploads\/2025\/12\/neurology-banner-image66c5de85306c0.webp","type":"image\/webp"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/clsconf.com\/neurology\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\/#article","isPartOf":{"@id":"https:\/\/clsconf.com\/neurology\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\/"},"author":{"name":"admin","@id":"https:\/\/clsconf.com\/neurology\/#\/schema\/person\/985869a73316c56939b28199bbeb71e6"},"headline":"Reinventing Migraine Care in Europe: Insights, Innovation & Investment Trends","datePublished":"2025-12-04T10:15:31+00:00","dateModified":"2025-12-04T10:21:41+00:00","mainEntityOfPage":{"@id":"https:\/\/clsconf.com\/neurology\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\/"},"wordCount":488,"commentCount":0,"publisher":{"@id":"https:\/\/clsconf.com\/neurology\/#organization"},"image":{"@id":"https:\/\/clsconf.com\/neurology\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\/#primaryimage"},"thumbnailUrl":"https:\/\/clsconf.com\/neurology\/wp-content\/uploads\/2025\/12\/neurology-banner-image66c5de85306c0.webp","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/clsconf.com\/neurology\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/clsconf.com\/neurology\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\/","url":"https:\/\/clsconf.com\/neurology\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\/","name":"Reinventing Migraine Care in Europe: Insights, Innovation & Investment Trends","isPartOf":{"@id":"https:\/\/clsconf.com\/neurology\/#website"},"primaryImageOfPage":{"@id":"https:\/\/clsconf.com\/neurology\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\/#primaryimage"},"image":{"@id":"https:\/\/clsconf.com\/neurology\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\/#primaryimage"},"thumbnailUrl":"https:\/\/clsconf.com\/neurology\/wp-content\/uploads\/2025\/12\/neurology-banner-image66c5de85306c0.webp","datePublished":"2025-12-04T10:15:31+00:00","dateModified":"2025-12-04T10:21:41+00:00","description":"Migraine Conference: Discover how migraine burden is transforming Europe\u2019s neuro-health landscape \u2014 from patient demand and treatment gaps to emerging technologies and research leaders \u2014 and join Neurology Congress.","breadcrumb":{"@id":"https:\/\/clsconf.com\/neurology\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/clsconf.com\/neurology\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/clsconf.com\/neurology\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\/#primaryimage","url":"https:\/\/clsconf.com\/neurology\/wp-content\/uploads\/2025\/12\/neurology-banner-image66c5de85306c0.webp","contentUrl":"https:\/\/clsconf.com\/neurology\/wp-content\/uploads\/2025\/12\/neurology-banner-image66c5de85306c0.webp","width":1926,"height":1000},{"@type":"BreadcrumbList","@id":"https:\/\/clsconf.com\/neurology\/reinventing-migraine-care-in-europe-insights-innovation-investment-trends\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/clsconf.com\/neurology\/"},{"@type":"ListItem","position":2,"name":"Reinventing Migraine Care in Europe: Insights, Innovation & Investment Trends"}]},{"@type":"WebSite","@id":"https:\/\/clsconf.com\/neurology\/#website","url":"https:\/\/clsconf.com\/neurology\/","name":"Neurology Conference 2026 | Psychiatry Congress | Neuro Congress","description":"Join the leading Neurology Conference 2026, a global platform for neurologists, psychiatrists, and researchers. Explore the latest advancements in neurology, neuroscience, and psychiatry. Register now! Embark on a transformative journey at the 4th European Congress of Neurology and Neuropsychiatry in Paris, France, on February 23-24, 2026","publisher":{"@id":"https:\/\/clsconf.com\/neurology\/#organization"},"alternateName":"Neurology Conference | Psychiatry Conference","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/clsconf.com\/neurology\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/clsconf.com\/neurology\/#organization","name":"CLS Event and Publication","alternateName":"CLS Event and Publication","url":"https:\/\/clsconf.com\/neurology\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/clsconf.com\/neurology\/#\/schema\/logo\/image\/","url":"https:\/\/clsconf.com\/neurology\/wp-content\/uploads\/2025\/11\/cropped-Logo-2026-1-Picsart-BackgroundRemover-1-1.png","contentUrl":"https:\/\/clsconf.com\/neurology\/wp-content\/uploads\/2025\/11\/cropped-Logo-2026-1-Picsart-BackgroundRemover-1-1.png","width":500,"height":282,"caption":"CLS Event and Publication"},"image":{"@id":"https:\/\/clsconf.com\/neurology\/#\/schema\/logo\/image\/"},"description":"CLS Event and Publication Ltd is a UK-based company specialising in international conferences, exhibitions, and scientific publishing. We bring together academics, researchers, healthcare professionals, and industry leaders to share expertise, foster collaborations, and showcase innovations.","email":"info@clsconf.com","legalName":"CLS EVENTS","foundingDate":"2021-02-01","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"11","maxValue":"50"},"publishingPrinciples":"https:\/\/clsconf.com\/neurology\/refundpolicy-faqs\/","ownershipFundingInfo":"https:\/\/clsconf.com\/neurology\/about-us\/","actionableFeedbackPolicy":"https:\/\/clsconf.com\/neurology\/scientific-poster-presentation-guidelines\/"},{"@type":"Person","@id":"https:\/\/clsconf.com\/neurology\/#\/schema\/person\/985869a73316c56939b28199bbeb71e6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9338361e5fda6e1a51464119e2265a669174adbf4e41e0060b272dd89c05786a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9338361e5fda6e1a51464119e2265a669174adbf4e41e0060b272dd89c05786a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9338361e5fda6e1a51464119e2265a669174adbf4e41e0060b272dd89c05786a?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/clsconf.com\/neurology\/author\/expertmeetcogmail-com\/"}]}},"_links":{"self":[{"href":"https:\/\/clsconf.com\/neurology\/wp-json\/wp\/v2\/posts\/4903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clsconf.com\/neurology\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clsconf.com\/neurology\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clsconf.com\/neurology\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clsconf.com\/neurology\/wp-json\/wp\/v2\/comments?post=4903"}],"version-history":[{"count":0,"href":"https:\/\/clsconf.com\/neurology\/wp-json\/wp\/v2\/posts\/4903\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clsconf.com\/neurology\/wp-json\/wp\/v2\/media\/4862"}],"wp:attachment":[{"href":"https:\/\/clsconf.com\/neurology\/wp-json\/wp\/v2\/media?parent=4903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clsconf.com\/neurology\/wp-json\/wp\/v2\/categories?post=4903"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clsconf.com\/neurology\/wp-json\/wp\/v2\/tags?post=4903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}